BioTech News
-
Macrogen, Exosome Plus to jointly develop exosome-based diagnostic & treatment solutions
BioTech | News | 0 Comment | 24 Apr, 2019
The precision medicine and biotechnology company Macrogen has announced on April 24 that it had signed a supply contract with Exosome Plus on April 19 to become the exclusive...Read more
-
Velabs collaborates with Chiome for GPCR-Specific functional antibody screening
BioTech | News | 0 Comment | 24 Apr, 2019
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has entered into an agreement with Chiome Bioscience, Inc., Tokyo, to jointl...Read more
-
Gracell Bio develops technology for Hematological Malignancies
BioTech | News | 0 Comment | 24 Apr, 2019
Gracell Biotechnologies is an immune cell gene therapy company, headquartered in Suzhou, China, with additional locations in Shanghai and Hong Kong. Gracell recently ann...Read more
-
Biotech startup RWDC raises $22 M in A3 round
BioTech | News | 0 Comment | 24 Apr, 2019
RWDC Industries Ltd, a Singapore-based biotech start-up, has announced that it has raised US$22 million in an oversubscribed Series A3 round, led by Vickers Venture Partners ...Read more
-
I-Mab, WuXi enter into long-term strategic manufacturing partnership
BioTech | News | 0 Comment | 24 Apr, 2019
I-Mab Biopharma (I-Mab), a biotech company focusing exclusively on innovative biologics in immuno-oncology and auto-immune diseases, and WuXi Biologics, a leading global open-access biologi...Read more
-
Bio-Rad appoints Andrew Last as Executive VP and COO
BioTech | News | 0 Comment | 23 Apr, 2019
Bio-Rad Laboratories, a global leader of life science research and clinical diagnostic products has announced the appointment of Dr. Andrew Last as Executive Vice President and Chief O...Read more
-
Circle DNA launches Next-Gen consumer genetic test
BioTech | News | 0 Comment | 23 Apr, 2019
Circle DNA, a Joint Venture company formed by Berry Genomics and Prenetics, announced today at a media press conference attended by over 100+ media, the launch of a Next Generation Con...Read more
-
Elpiscience, Bio-Techne to develop anti-cancer therapeutics
BioTech | News | 0 Comment | 23 Apr, 2019
Elpiscience BioPharma and Bio-Techne Corporation have announced that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the te...Read more
-
BioTech | News | 0 Comment | 22 Apr, 2019
Maxinovel Pharmaceuticals presented in the 2019 AACR the head to head comparison of its orally active small molecule PD-L1 inhibitor with commercially marketed PD-L1 antibody drug Durvaluma...Read more
-
Jackson ImmunoResearch launches secondary antibodies for VHH discovery
BioTech | News | 0 Comment | 17 Apr, 2019
Jackson ImmunoResearch, manufacturer of secondary antibodies for the life science market, announces a new range of products for scientists developing single-domain VHH antibodies. The new ...Read more
-
BioAtla , Himalaya Therapeutics to develop, market CAB Products in China
BioTech | News | 0 Comment | 16 Apr, 2019
BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics for the oncology market has ann...Read more
-
Insilico opens office in Singapore to expand biz in Asia
BioTech | News | 0 Comment | 16 Apr, 2019
Insilico Biotechnology AG announces the opening of a representation in Singapore to develop its business in the Asia-Pacific (APAC) region and to strengthen support for its growing customer...Read more
-
Chinese CDMO, GenScript starts construction of Biotech Commercial Manufacturing Center
BioTech | News | 0 Comment | 15 Apr, 2019
GenScript Biotech Corp, a leading Chinese bio-pharmaceutical contract development and manufacturing organization (CDMO), held the groundbreaking ceremony for the start of con...Read more
-
Synaffix announces license agreement with Miracogen worth $125M
BioTech | News | 0 Comment | 12 Apr, 2019
Synaffix BV, a Dutch biotechnology company exclusively focused on continued advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the development of best-in-class A...Read more
-
EdiGene raises $15 M in Series B funding
BioTech | News | 0 Comment | 11 Apr, 2019
EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic disorders has announced that it has raised 1.6 Billion-yen (approx. $15 Million...Read more
-
Six Indian Institutes establish joint Doctoral Training Group on Bio Big Data Science
BioTech | News | 0 Comment | 11 Apr, 2019
Six leading Indian Institutes of Higher Education are collaborating to establish up the first Joint Indian-German Research Training Group (RTG) on Bio Big Data Science to promote the use of...Read more
-
Japan approves Rakuten Medical's ASP-1929 to treat cancer
BioTech | News | 0 Comment | 10 Apr, 2019
Based on its exclusive license related to photoimmunotherapy, Rakuten Medical Inc., which is developing a cancer therapy to target cancer cells, announced that ASP-1929 received Sakigake de...Read more
-
WuXi Bio, NBE-Therapeutics announce ADC partnership
BioTech | News | 0 Comment | 10 Apr, 2019
WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, a...Read more
